Skip to main content
. 2015 Oct 2;6(31):31569–31592. doi: 10.18632/oncotarget.5035

Table 2. Validation of microarray data by RT-PCR.

Gene Method Mean FC size of tumors
small middle large
Cdk4 RT-PCR 3.0 2.0 1.4
Affymetrix 2.7 2.1 2.9
Stk6 RT-PCR 6.6 3.1 4.1
Affymetrix 6.4 3.4 4.2
Nek6 RT-PCR 3.0 2.6 2.9
Affymetrix 3.1 3.2 3.5
Ccnb1 RT-PCR 9.5 4.0 5.4
Affymetrix 22.2 9.4 12.8
Cdc2a RT-PCR 13.3 6.5 8.3
Affymetrix 18.0 10.6 10.5
Prc1 RT-PCR 8.0 5.1 5.5
Affymetrix 6.0 3.0 4.2
Birc5 RT-PCR 10.1 4.8 4.9
Affymetrix 8.6 4.5 6.0
Hey1 RT-PCR A −1.9 A
Affymetrix −4,9 −3.7 −5,1
Ddit3 RT-PCR −4.0 −3.5 −5.9
Affymetrix −2,3 −3,5 −6,2

A - “Absent” - no gene expression was detected

The gene expression values in all samples were normalized to the beta-actin expression and used to calculate mean expression values for tumors of various sizes and control lung tissue extracts. The mean fold change was computed as a ratio between mean gene expression values for tumor sets and control non-transgenic lung as a baseline.